| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |